Since 1990, CEDRA Corporation has provided GLP bioanalytical chemistry services to the federal government, pharmaceutical and biotechnology industries. In recent years, we have added capabilities in other areas to provide our clients with a comprehensive service package, including bioequivalency and statistics/pharmacokinetics, as well as clinical services.
Our services are exceptional, supported by a philosophy of building loyalty and long-term relationships. We uphold this philosophy through a progressive company-wide emphasis on integrity, teamwork, and good science. It’s not just talk—innovative programs such as our Child Development Center express our commitment to our employees. And in the long run, the commitment we receive in return benefits both our company and our clients.
Learn more about CEDRA at an upcoming event.
Review abstracts of CEDRA's posters, presented at the 2002-2007 AAPS Annual Meeting and Exposition
Download CEDRA's list of bioanalytical methods
Latest News
CEDRA joins Worldwide Clinical Trials
CEDRA Corporation and CEDRA Clinical Research are pleased to announce a change of ownership and that we are now part of Worldwide Clinical Trials (WCT). The CEDRA organization will continue to operate under the CEDRA name and will remain intact as an organization.
By becoming part of the WCT organization, CEDRA will gain additional medical and scientific expertise and be a part of providing Phase I-IV clinical capabilities to our clients. WCT is a global organization and CEDRA will now be able to support international clients in their Phase I and bioanalytical needs.
